• 1
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
TMLHE (HGNC:18308) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
trimethyllysine hydroxylase, epsilon
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
No previous names found
Alias symbols
TMLH, FLJ10727, BBOX2, XAP130
%HI
63.26(Read more about the DECIPHER Haploinsufficiency Index)
pLI
0(Read more about gnomAD pLI score)
LOEUF
1.18(Read more about gnomAD LOEUF score)
Cytoband
Xq28
Genomic Coordinates
GRCh37/hg19: chrX:154718672-154842613 NCBI Ensembl UCSC
GRCh38/hg38: chrX:155489011-155612952 NCBI Ensembl UCSC
MANE Select Transcript
NM_018196.4 ENST00000334398.8 (Read more about MANE Select)
Function
Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML) (PubMed:11431483, PubMed:23092983). {ECO:0000269|PubMed:11431483, ECO:0000269|PubMed:23092983}. (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-22301
ClinGen Curation ID:
CCID:008018
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Little Evidence for Haploinsufficiency (1)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
08/01/2013

Haploinsufficiency (HI) Score Details

HI Score:
1
HI Evidence Strength:
Little Evidence for Haploinsufficiency (Disclaimer)
HI Evidence:
  • PUBMED: 21865298
    Celestino-Soper et al., 2011 performed array CGH on 99 trios from the Simons Simplex Collection autism family collection and identified a maternally inherited intragenic TMLHE exon 2 deletion in a male proband. The same deletion was noted to be present in a healthy CEPH male.
  • PUBMED: 22566635
    Celestino-Soper et al., 2012 showed that exon 2 deletions result in a loss-of-function and examined the frequency of TMLHE mutations in autism and control populations. From abstract: "TMLHE deficiency is common in control males (24 in 8,787 or 1 in 366) and was not significantly increased in frequency in probands from simplex autism families (9 in 2,904 or 1 in 323). However, it was 2.82-fold more frequent in probands from male-male multiplex autism families compared with controls (7 in 909 or 1 in 130; P = 0.023). Additionally, six of seven autistic male siblings of probands in male-male multiplex families had the deletion, suggesting that TMLHE deficiency is a risk factor for autism (metaanalysis Z-score = 2.90 and P = 0.0037), although with low penetrance (2-4%)."
  • PUBMED: 23092983
    Nava et al. 2012 performed NGS of the chromosome X exome for 12 unrelated families with two males affected with autism spectrum disorder (ASD) and identified a maternally inherited TMLHE nonsense mutation in one family that was absent from 508 healthy male controls. Screening an additional 501 unrelated male patients with ASD for mutations in the TMLHE coding sequence identified two maternally inherited missense mutations predicted to result in a loss-of-function that were absent from 765 healthy male controls. A separate assessment of intragenic TMLHE copy number variant frequency identified exon 2 deletions in one of 896 healthy male controls vs. 3 of 691 male patients with ASD, however one of the three ASD probands had an affected brother who did not carry the exon 2 deletion.
HI Evidence Comments:
The current opinion regarding TMLHE deficiency is that it represents a weak risk factor for autism in males, with an estimated penetrance of 2-4% (Celestino-Soper et al., 2012), however additional replication studies are necessary. Due to the relative prevalence of TMLHE mutations in healthy males in control populations, the significance of TMLHE nullisomy is uncertain at this time. Female carriers are presumed to be unaffected.
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)